Direct Sequencing Measures Mutation Rate in Humans
By LabMedica International staff writers Posted on 10 Sep 2009 |
An international team of 16 scientists reported the first direct measurement of the general rate of genetic mutation at individual DNA letters in humans. The team sequenced the same piece of DNA--10,000,000 or so letters (nucleotides) from the Y chromosome--from two men separated by 13 generations, and counted the number of differences. Among all these nucleotides, they found only four mutations.
In 1935, one of the founders of modern genetics, J. B. S. Haldane, studied men in London (UK) with the blood disease hemophilia and estimated that there would be one in 50,000 incidence of mutations causing hemophilia in the gene affected--the equivalent of a mutation rate of possibly one in 25 million nucleotides across the genome. Others have measured rates at a few additional specific genes or compared DNA from humans and chimpanzees to produce general estimates of the mutation rate expressed more directly in nucleotides of DNA.
Extraordinarily, the new research, published in the August 27, 2009, issue of the journal Current Biology, revealed that these early estimates were correct--in total, humans all carry 100-200 new mutations in their DNA. This is equivalent to one mutation in each 15-30 million nucleotides. Fortunately, most of these are harmless and have no apparent effect on one's health or appearance. "The amount of data we generated would have been unimaginable just a few years ago,” said Dr. Yali Xue, from the Wellcome Trust Sanger Institute (Cambridge, UK), and one of the project's leaders. "But finding this tiny number of mutations was more difficult than finding an ant's egg in the emperor's rice store.”
Team member Qiuju Wang recruited a family from China who had lived in the same village for centuries. The team studied two distant male-line relatives--separated by thirteen generations--whose common ancestor lived 200 years ago. To establish the rate of mutation, the team examined an area of the Y chromosome. The Y chromosome is unique in that, apart from rare mutations, it is passed unchanged from father to son, so mutations accumulate slowly over the generations. Despite many generations of separation, researchers discovered only 12 differences among all the DNA letters examined. The two Y-chromosomes were still identical at 10,149,073 of the 10,149,085 letters examined. Of the 12 differences, eight had arisen in the cell lines used for the work. Only four were true mutations that had occurred naturally through the generations.
Scientists have known for a long time that mutations occur occasionally in each human being, but have had to guess precisely how often. Now, because advances in the technology for reading DNA, this new research has been possible, according to the investigators.
Understanding mutation rates is key to many aspects of human evolution and medical research: mutation is the ultimate source of all genetic variation and provides a molecular clock for measuring evolutionary timescales. Mutations can also lead directly to diseases such as cancer. With better measurements of mutation rates, scientists could improve the calibration of the evolutionary clock, or test ways to reduce mutations, for example.
Even with the latest DNA sequencing technology, the researchers had to design a special strategy to search for the vanishingly rare mutations. They used next-generation sequencing to establish the order of letters on the two Y-chromosomes and then compared these to the Y chromosome reference sequence.
Having identified 23 candidate single nucleotide polymorphisms (SNPs)--or single letter changes in the DNA--the investigators amplified the regions containing these candidates and checked the sequences using the standard Sanger method. Four naturally occurring mutations were confirmed. Knowing this number of mutations, the length of the area that they had searched, and the number of generations separating the individuals, the team was able to calculate the rate of mutation.
"These four mutations gave us the exact mutation rate--one in 30 million nucleotides each generation--that we had expected,” stated the study's coordinator, Chris Tyler-Smith, also from The Wellcome Trust Sanger Institute. "This was reassuring because the methods we used--harnessing next-generation sequencing technology--had not previously been tested for this kind of research. New mutations are responsible for an array of genetic diseases. The ability to reliably measure rates of DNA mutation means we can begin to ask how mutation rates vary between different regions of the genome and perhaps also between different individuals.”
Participating Centers involved in the project include: The Wellcome Trust Sanger Institute (Hinxton, Cambridgeshire, UK); Chinese People's Liberation Army General Hospital (Beijing, China); and Beijing Genomics Institute at Shenzhen (China).
Related Links:
Wellcome Trust Sanger Institute
In 1935, one of the founders of modern genetics, J. B. S. Haldane, studied men in London (UK) with the blood disease hemophilia and estimated that there would be one in 50,000 incidence of mutations causing hemophilia in the gene affected--the equivalent of a mutation rate of possibly one in 25 million nucleotides across the genome. Others have measured rates at a few additional specific genes or compared DNA from humans and chimpanzees to produce general estimates of the mutation rate expressed more directly in nucleotides of DNA.
Extraordinarily, the new research, published in the August 27, 2009, issue of the journal Current Biology, revealed that these early estimates were correct--in total, humans all carry 100-200 new mutations in their DNA. This is equivalent to one mutation in each 15-30 million nucleotides. Fortunately, most of these are harmless and have no apparent effect on one's health or appearance. "The amount of data we generated would have been unimaginable just a few years ago,” said Dr. Yali Xue, from the Wellcome Trust Sanger Institute (Cambridge, UK), and one of the project's leaders. "But finding this tiny number of mutations was more difficult than finding an ant's egg in the emperor's rice store.”
Team member Qiuju Wang recruited a family from China who had lived in the same village for centuries. The team studied two distant male-line relatives--separated by thirteen generations--whose common ancestor lived 200 years ago. To establish the rate of mutation, the team examined an area of the Y chromosome. The Y chromosome is unique in that, apart from rare mutations, it is passed unchanged from father to son, so mutations accumulate slowly over the generations. Despite many generations of separation, researchers discovered only 12 differences among all the DNA letters examined. The two Y-chromosomes were still identical at 10,149,073 of the 10,149,085 letters examined. Of the 12 differences, eight had arisen in the cell lines used for the work. Only four were true mutations that had occurred naturally through the generations.
Scientists have known for a long time that mutations occur occasionally in each human being, but have had to guess precisely how often. Now, because advances in the technology for reading DNA, this new research has been possible, according to the investigators.
Understanding mutation rates is key to many aspects of human evolution and medical research: mutation is the ultimate source of all genetic variation and provides a molecular clock for measuring evolutionary timescales. Mutations can also lead directly to diseases such as cancer. With better measurements of mutation rates, scientists could improve the calibration of the evolutionary clock, or test ways to reduce mutations, for example.
Even with the latest DNA sequencing technology, the researchers had to design a special strategy to search for the vanishingly rare mutations. They used next-generation sequencing to establish the order of letters on the two Y-chromosomes and then compared these to the Y chromosome reference sequence.
Having identified 23 candidate single nucleotide polymorphisms (SNPs)--or single letter changes in the DNA--the investigators amplified the regions containing these candidates and checked the sequences using the standard Sanger method. Four naturally occurring mutations were confirmed. Knowing this number of mutations, the length of the area that they had searched, and the number of generations separating the individuals, the team was able to calculate the rate of mutation.
"These four mutations gave us the exact mutation rate--one in 30 million nucleotides each generation--that we had expected,” stated the study's coordinator, Chris Tyler-Smith, also from The Wellcome Trust Sanger Institute. "This was reassuring because the methods we used--harnessing next-generation sequencing technology--had not previously been tested for this kind of research. New mutations are responsible for an array of genetic diseases. The ability to reliably measure rates of DNA mutation means we can begin to ask how mutation rates vary between different regions of the genome and perhaps also between different individuals.”
Participating Centers involved in the project include: The Wellcome Trust Sanger Institute (Hinxton, Cambridgeshire, UK); Chinese People's Liberation Army General Hospital (Beijing, China); and Beijing Genomics Institute at Shenzhen (China).
Related Links:
Wellcome Trust Sanger Institute
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more
Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more
Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Approximately one in three women aged 14-49 in the United States will experience bacterial vaginosis (BV), a vaginal bacterial imbalance, at some point in their lives. Around 50% of BV cases do not present... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more